查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1573161

心血管手术设备市场：按产品类型、手术类型和最终用户划分 - 全球预测 2025-2030 年

Cardiovascular Surgery Devices Market by Product Type (Cardiopulmonary Bypass Equipment, Heart Valve Devices, Perfusion Disposables), Procedure Type (Cardiovascular Surgery, Coronary Artery Bypass Grafting (CABG)), End User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 184 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年心血管手术器械市场价值为15.7亿美元，预计到2024年将达到16.5亿美元，复合年增长率为5.43%，到2030年将达到22.7亿美元。

心血管手术设备市场包括各种专为诊断、治疗和管理心血管疾病而设计的仪器和设备。该市场包括冠状动脉绕道手术手术（CABG）、心臟瓣膜修復和心臟瓣膜置换术等外科手术的基本设备，如心肺机、导管、支架和移植物。由于人口老化、久坐的生活方式和肥胖率的增加，心血管疾病的发生率不断增加，因此需要这些设备。这些设备用于医院、心臟专科护理中心、门诊病人设施等，在传统手术和微创手术中发挥重要作用。

主要市场统计
基准年[2023] 15.7亿美元
预测年份 [2024] 16.5亿美元
预测年份 [2030] 22.7亿美元
复合年增长率（%） 5.43%

市场成长受到多种因素的影响，例如技术进步、对微创手术的日益偏好以及主要企业的大量研发投资。最近的趋势，例如将人工智慧和物联网整合到手术设备中，透过提供即时资料分析和预测结果来提高手术成功率，从而释放潜在的机会。鼓励公司专注于产品创新、基于价值的护理模式和策略伙伴关係关係，以利用这些机会。相反，高昂的设备成本、严格的监管核准以及缺乏熟练的外科医生等限制因素给市场扩张带来了挑战。特别是在新兴市场，监管合规障碍可能会阻碍产品的快速发布和采用。

生物可吸收血管支架、机器人辅助手术以及结合传统技术和导管技术的混合导管实验室手术环境等领域存在大量创新和研究机会。开发提高手术精度和缩短恢復时间的解决方案可以提供竞争优势。此外，由于快速的技术变革和医疗保健报销政策，市场的本质是高度动态的。透过专注于这些创新路径并适应监管环境，公司可以在这个不断发展的生态系统中获得强大的地位，并可持续地满足对有效心血管手术解决方案不断增长的需求，从而促进成长。

市场动态：快速发展的心血管手术器材市场的关键市场洞察

供需的动态交互作用正在改变心血管手术器械市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时消费行为及其对製造成本的影响以及对采购趋势的影响。

  • 市场驱动因素
    • 由于生活方式和饮食的改变导致心血管疾病的盛行率增加，导致手术干预的增加
    • 心血管手术设备的快速技术进步和创新可改善患者的治疗效果
    • 由于人口老化更容易罹患心臟病，心血管手术的需求增加
    • 扩大新兴市场的医疗保健基础设施和先进医疗设施
  • 市场限制因素
    • 心血管外科的先进手术和材料高成本
  • 市场机会
    • 将人工智慧和机器学习整合到手术设备中
    • 心血管手术器械：由于技术进步和人口老化，对微创手术的需求不断增长
  • 市场挑战
    • 替代疗法和非侵入性心血管手术的竞争加剧。

波特五力：驾驭心血管手术器械市场的策略工具

波特的五力框架是理解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解心血管手术器械市场的外部影响

外部宏观环境因素在塑造心血管手术器械市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析 了解心血管手术器材市场的竞争格局

心血管手术设备市场的详细市场占有率分析可以对供应商的业绩进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵心血管手术器械市场供应商的绩效评估

FPNV 定位矩阵是评估心血管手术设备市场供应商的重要工具。此矩阵允许业务组织根据供应商的商务策略和产品满意度评估供应商，从而做出符合其目标的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议描绘了心血管手术器械市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，对心血管手术器械市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机，并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：对当前市场环境的详细审查、主要企业的广泛资料、对其在市场中的影响力和整体影响力的评估。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 生活方式和饮食的改变正在增加心血管疾病的发生率并增加对手术干预的需求。
      • 心血管手术设备的快速技术进步和创新可改善患者的治疗效果
      • 由于人口老化，更容易患心臟病，对心血管手术的需求不断增加。
      • 扩大新兴市场的医疗保健基础设施和先进医疗设施
    • 抑制因素
      • 心血管外科的先进手术和材料高成本
    • 机会
      • 将人工智慧和机器学习整合到手术设备中
      • 技术进步和人口老化正在增加对微创心血管手术设备的需求
    • 任务
      • 来自替代疗法和非侵入性心血管手术的竞争正在加剧。
  • 市场区隔分析
  • 波特五力分析
  • PESTLE分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章心血管手术器械市场：依产品类型

  • 心肺机
    • 插管
    • 供氧装置
    • 水库
  • 心臟瓣膜装置
    • 人工心臟瓣膜
    • 组织心臟瓣膜
    • 经导管心臟瓣膜
  • 抛弃式
    • 血液心臟麻痹

第七章依手术类型分類的心血管手术器械市场

  • 心血管外科
  • 冠状动脉绕道手术手术（CABG）

第八章心血管手术设备市场：依最终用户分类

  • 心臟中心
  • 医院

第九章美洲心血管手术器械市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十章亚太地区心血管手术器械市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十一章欧洲、中东和非洲心血管手术器材市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十二章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争场景分析
  • 战略分析和建议
Product Code: MRR-535C6291876B

The Cardiovascular Surgery Devices Market was valued at USD 1.57 billion in 2023, expected to reach USD 1.65 billion in 2024, and is projected to grow at a CAGR of 5.43%, to USD 2.27 billion by 2030.

The cardiovascular surgery devices market encompasses a broad array of instruments and equipment designed for the diagnosis, treatment, and management of cardiovascular disorders. This market includes devices such as heart-lung machines, catheters, stents, and grafts, essential for surgical procedures like coronary artery bypass grafting (CABG), heart valve repair, and replacement. The necessity of these devices stems from the rising incidence of cardiovascular diseases fueled by aging populations, sedentary lifestyles, and increasing obesity rates. These devices find application in hospitals, specialized cardiac care centers, and outpatient facilities, serving a critical role in both conventional and minimally invasive surgical procedures.

KEY MARKET STATISTICS
Base Year [2023] USD 1.57 billion
Estimated Year [2024] USD 1.65 billion
Forecast Year [2030] USD 2.27 billion
CAGR (%) 5.43%

Market growth is influenced by several factors, including technological advancements, growing preference for minimally invasive surgery, and extensive R&D investment by key players. Recent trends such as the integration of AI and IoT in surgical devices have unlocked potential opportunities by offering real-time data analytics and predictive outcomes, improving surgery success rates. Companies are encouraged to focus on product innovation, value-based care models, and strategic partnerships to leverage these opportunities. Conversely, limitations such as high device costs, stringent regulatory approvals, and the shortage of skilled surgeons pose challenges to market expansion. Regulatory compliance hurdles, particularly in emerging markets, can hinder swift product launches and adoption.

Opportunities for innovation and research are abundant in areas like bioresorbable vascular scaffolds, robot-assisted surgery, and hybrid cath lab operating environments where traditional and catheter-based procedures are combined. Developing solutions that enhance surgical precision and reduce recovery times can offer a competitive advantage. Additionally, the market nature is highly dynamic due to rapid technological shifts and healthcare reimbursement policies. By focusing on these innovation avenues and adapting to regulatory landscapes, businesses can position themselves strongly in this evolving ecosystem, driving sustained growth while meeting the increasing demand for efficient cardiovascular surgical solutions.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Cardiovascular Surgery Devices Market

The Cardiovascular Surgery Devices Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Growing incidence of cardiovascular diseases due to lifestyle and dietary changes leading to higher surgical interventions
    • Rapid technological advancements and innovation in cardiovascular surgery devices improving patient outcomes
    • Increasing aging population prone to heart conditions boosting demand for cardiovascular surgery procedures
    • Expansion of healthcare infrastructure and access to advanced medical facilities in emerging markets
  • Market Restraints
    • High Cost for advance procedure and material in cardiovascular surgery
  • Market Opportunities
    • Integration of artificial intelligence and machine learning in surgical device
    • Growing demand for minimally invasive cardiovascular surgery devices driven by technological advancements and aging population
  • Market Challenges
    • Increased competition from alternative treatments and non-invasive cardiovascular procedures.

Porter's Five Forces: A Strategic Tool for Navigating the Cardiovascular Surgery Devices Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Cardiovascular Surgery Devices Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Cardiovascular Surgery Devices Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Cardiovascular Surgery Devices Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Cardiovascular Surgery Devices Market

A detailed market share analysis in the Cardiovascular Surgery Devices Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Cardiovascular Surgery Devices Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Cardiovascular Surgery Devices Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Cardiovascular Surgery Devices Market

A strategic analysis of the Cardiovascular Surgery Devices Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Cardiovascular Surgery Devices Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Biotronik SE & Co. KG, Boston Scientific Corporation, Canon Medical Systems Corporation, Edwards Lifesciences Corporation, Fresenius Medical Care AG & Co. KGaA, GE HealthCare Technologies Inc., Getinge AB, Johnson & Johnson, LivaNova PLC, Maquet Cardiovascular LLC, Medtronic plc, MicroPort Scientific Corporation, Philips Healthcare, Siemens Healthineers AG, St. Jude Medical, Inc., Stryker Corporation, Terumo Corporation, W. L. Gore & Associates, Inc., and Zimmer Biomet Holdings, Inc..

Market Segmentation & Coverage

This research report categorizes the Cardiovascular Surgery Devices Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product Type, market is studied across Cardiopulmonary Bypass Equipment, Heart Valve Devices, and Perfusion Disposables. The Cardiopulmonary Bypass Equipment is further studied across Cannulae, Oxygenators, and Reservoirs. The Heart Valve Devices is further studied across Mechanical Heart Valves, Tissue Heart Valves, and Transcatheter Heart Valves. The Perfusion Disposables is further studied across Blood Cardioplegia.
  • Based on Procedure Type, market is studied across Cardiovascular Surgery and Coronary Artery Bypass Grafting (CABG).
  • Based on End User, market is studied across Cardiac Centers and Hospitals.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing incidence of cardiovascular diseases due to lifestyle and dietary changes leading to higher surgical interventions
      • 5.1.1.2. Rapid technological advancements and innovation in cardiovascular surgery devices improving patient outcomes
      • 5.1.1.3. Increasing aging population prone to heart conditions boosting demand for cardiovascular surgery procedures
      • 5.1.1.4. Expansion of healthcare infrastructure and access to advanced medical facilities in emerging markets
    • 5.1.2. Restraints
      • 5.1.2.1. High Cost for advance procedure and material in cardiovascular surgery
    • 5.1.3. Opportunities
      • 5.1.3.1. Integration of artificial intelligence and machine learning in surgical device
      • 5.1.3.2. Growing demand for minimally invasive cardiovascular surgery devices driven by technological advancements and aging population
    • 5.1.4. Challenges
      • 5.1.4.1. Increased competition from alternative treatments and non-invasive cardiovascular procedures.
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Cardiovascular Surgery Devices Market, by Product Type

  • 6.1. Introduction
  • 6.2. Cardiopulmonary Bypass Equipment
    • 6.2.1. Cannulae
    • 6.2.2. Oxygenators
    • 6.2.3. Reservoirs
  • 6.3. Heart Valve Devices
    • 6.3.1. Mechanical Heart Valves
    • 6.3.2. Tissue Heart Valves
    • 6.3.3. Transcatheter Heart Valves
  • 6.4. Perfusion Disposables
    • 6.4.1. Blood Cardioplegia

7. Cardiovascular Surgery Devices Market, by Procedure Type

  • 7.1. Introduction
  • 7.2. Cardiovascular Surgery
  • 7.3. Coronary Artery Bypass Grafting (CABG)

8. Cardiovascular Surgery Devices Market, by End User

  • 8.1. Introduction
  • 8.2. Cardiac Centers
  • 8.3. Hospitals

9. Americas Cardiovascular Surgery Devices Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Cardiovascular Surgery Devices Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Cardiovascular Surgery Devices Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. Biotronik SE & Co. KG
  • 3. Boston Scientific Corporation
  • 4. Canon Medical Systems Corporation
  • 5. Edwards Lifesciences Corporation
  • 6. Fresenius Medical Care AG & Co. KGaA
  • 7. GE HealthCare Technologies Inc.
  • 8. Getinge AB
  • 9. Johnson & Johnson
  • 10. LivaNova PLC
  • 11. Maquet Cardiovascular LLC
  • 12. Medtronic plc
  • 13. MicroPort Scientific Corporation
  • 14. Philips Healthcare
  • 15. Siemens Healthineers AG
  • 16. St. Jude Medical, Inc.
  • 17. Stryker Corporation
  • 18. Terumo Corporation
  • 19. W. L. Gore & Associates, Inc.
  • 20. Zimmer Biomet Holdings, Inc.

LIST OF FIGURES

  • FIGURE 1. CARDIOVASCULAR SURGERY DEVICES MARKET RESEARCH PROCESS
  • FIGURE 2. CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. CARDIOVASCULAR SURGERY DEVICES MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. CARDIOVASCULAR SURGERY DEVICES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. CARDIOVASCULAR SURGERY DEVICES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. CARDIOVASCULAR SURGERY DEVICES MARKET DYNAMICS
  • TABLE 7. GLOBAL CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY CARDIOPULMONARY BYPASS EQUIPMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY CANNULAE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY OXYGENATORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY RESERVOIRS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY CARDIOPULMONARY BYPASS EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY HEART VALVE DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY MECHANICAL HEART VALVES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY TISSUE HEART VALVES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY TRANSCATHETER HEART VALVES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY HEART VALVE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PERFUSION DISPOSABLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY BLOOD CARDIOPLEGIA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PERFUSION DISPOSABLES, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY CARDIOVASCULAR SURGERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY CORONARY ARTERY BYPASS GRAFTING (CABG), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY CARDIAC CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY CARDIOPULMONARY BYPASS EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY HEART VALVE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PERFUSION DISPOSABLES, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 32. AMERICAS CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 33. AMERICAS CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 34. ARGENTINA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. ARGENTINA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY CARDIOPULMONARY BYPASS EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 36. ARGENTINA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY HEART VALVE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 37. ARGENTINA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PERFUSION DISPOSABLES, 2018-2030 (USD MILLION)
  • TABLE 38. ARGENTINA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 39. ARGENTINA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 40. BRAZIL CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. BRAZIL CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY CARDIOPULMONARY BYPASS EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 42. BRAZIL CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY HEART VALVE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 43. BRAZIL CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PERFUSION DISPOSABLES, 2018-2030 (USD MILLION)
  • TABLE 44. BRAZIL CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 45. BRAZIL CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 46. CANADA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. CANADA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY CARDIOPULMONARY BYPASS EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 48. CANADA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY HEART VALVE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 49. CANADA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PERFUSION DISPOSABLES, 2018-2030 (USD MILLION)
  • TABLE 50. CANADA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. CANADA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 52. MEXICO CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. MEXICO CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY CARDIOPULMONARY BYPASS EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 54. MEXICO CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY HEART VALVE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 55. MEXICO CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PERFUSION DISPOSABLES, 2018-2030 (USD MILLION)
  • TABLE 56. MEXICO CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 57. MEXICO CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 58. UNITED STATES CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 59. UNITED STATES CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY CARDIOPULMONARY BYPASS EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 60. UNITED STATES CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY HEART VALVE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 61. UNITED STATES CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PERFUSION DISPOSABLES, 2018-2030 (USD MILLION)
  • TABLE 62. UNITED STATES CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. UNITED STATES CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 64. UNITED STATES CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 65. ASIA-PACIFIC CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. ASIA-PACIFIC CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY CARDIOPULMONARY BYPASS EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 67. ASIA-PACIFIC CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY HEART VALVE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 68. ASIA-PACIFIC CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PERFUSION DISPOSABLES, 2018-2030 (USD MILLION)
  • TABLE 69. ASIA-PACIFIC CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. ASIA-PACIFIC CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 71. ASIA-PACIFIC CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 72. AUSTRALIA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. AUSTRALIA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY CARDIOPULMONARY BYPASS EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 74. AUSTRALIA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY HEART VALVE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 75. AUSTRALIA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PERFUSION DISPOSABLES, 2018-2030 (USD MILLION)
  • TABLE 76. AUSTRALIA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. AUSTRALIA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 78. CHINA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. CHINA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY CARDIOPULMONARY BYPASS EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 80. CHINA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY HEART VALVE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 81. CHINA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PERFUSION DISPOSABLES, 2018-2030 (USD MILLION)
  • TABLE 82. CHINA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. CHINA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 84. INDIA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. INDIA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY CARDIOPULMONARY BYPASS EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 86. INDIA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY HEART VALVE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 87. INDIA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PERFUSION DISPOSABLES, 2018-2030 (USD MILLION)
  • TABLE 88. INDIA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. INDIA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 90. INDONESIA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. INDONESIA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY CARDIOPULMONARY BYPASS EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 92. INDONESIA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY HEART VALVE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 93. INDONESIA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PERFUSION DISPOSABLES, 2018-2030 (USD MILLION)
  • TABLE 94. INDONESIA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. INDONESIA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 96. JAPAN CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. JAPAN CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY CARDIOPULMONARY BYPASS EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 98. JAPAN CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY HEART VALVE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 99. JAPAN CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PERFUSION DISPOSABLES, 2018-2030 (USD MILLION)
  • TABLE 100. JAPAN CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 101. JAPAN CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 102. MALAYSIA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 103. MALAYSIA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY CARDIOPULMONARY BYPASS EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 104. MALAYSIA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY HEART VALVE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 105. MALAYSIA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PERFUSION DISPOSABLES, 2018-2030 (USD MILLION)
  • TABLE 106. MALAYSIA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 107. MALAYSIA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 108. PHILIPPINES CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 109. PHILIPPINES CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY CARDIOPULMONARY BYPASS EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 110. PHILIPPINES CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY HEART VALVE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 111. PHILIPPINES CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PERFUSION DISPOSABLES, 2018-2030 (USD MILLION)
  • TABLE 112. PHILIPPINES CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 113. PHILIPPINES CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 114. SINGAPORE CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 115. SINGAPORE CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY CARDIOPULMONARY BYPASS EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 116. SINGAPORE CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY HEART VALVE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 117. SINGAPORE CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PERFUSION DISPOSABLES, 2018-2030 (USD MILLION)
  • TABLE 118. SINGAPORE CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 119. SINGAPORE CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 120. SOUTH KOREA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 121. SOUTH KOREA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY CARDIOPULMONARY BYPASS EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 122. SOUTH KOREA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY HEART VALVE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 123. SOUTH KOREA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PERFUSION DISPOSABLES, 2018-2030 (USD MILLION)
  • TABLE 124. SOUTH KOREA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 125. SOUTH KOREA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 126. TAIWAN CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 127. TAIWAN CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY CARDIOPULMONARY BYPASS EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 128. TAIWAN CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY HEART VALVE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 129. TAIWAN CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PERFUSION DISPOSABLES, 2018-2030 (USD MILLION)
  • TABLE 130. TAIWAN CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 131. TAIWAN CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 132. THAILAND CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 133. THAILAND CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY CARDIOPULMONARY BYPASS EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 134. THAILAND CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY HEART VALVE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 135. THAILAND CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PERFUSION DISPOSABLES, 2018-2030 (USD MILLION)
  • TABLE 136. THAILAND CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 137. THAILAND CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 138. VIETNAM CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 139. VIETNAM CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY CARDIOPULMONARY BYPASS EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 140. VIETNAM CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY HEART VALVE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 141. VIETNAM CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PERFUSION DISPOSABLES, 2018-2030 (USD MILLION)
  • TABLE 142. VIETNAM CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 143. VIETNAM CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 144. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 145. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY CARDIOPULMONARY BYPASS EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 146. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY HEART VALVE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 147. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PERFUSION DISPOSABLES, 2018-2030 (USD MILLION)
  • TABLE 148. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 149. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 150. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 151. DENMARK CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 152. DENMARK CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY CARDIOPULMONARY BYPASS EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 153. DENMARK CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY HEART VALVE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 154. DENMARK CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PERFUSION DISPOSABLES, 2018-2030 (USD MILLION)
  • TABLE 155. DENMARK CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 156. DENMARK CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 157. EGYPT CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 158. EGYPT CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY CARDIOPULMONARY BYPASS EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 159. EGYPT CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY HEART VALVE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 160. EGYPT CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PERFUSION DISPOSABLES, 2018-2030 (USD MILLION)
  • TABLE 161. EGYPT CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 162. EGYPT CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 163. FINLAND CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 164. FINLAND CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY CARDIOPULMONARY BYPASS EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 165. FINLAND CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY HEART VALVE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 166. FINLAND CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PERFUSION DISPOSABLES, 2018-2030 (USD MILLION)
  • TABLE 167. FINLAND CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 168. FINLAND CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 169. FRANCE CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 170. FRANCE CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY CARDIOPULMONARY BYPASS EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 171. FRANCE CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY HEART VALVE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 172. FRANCE CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PERFUSION DISPOSABLES, 2018-2030 (USD MILLION)
  • TABLE 173. FRANCE CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 174. FRANCE CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 175. GERMANY CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 176. GERMANY CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY CARDIOPULMONARY BYPASS EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 177. GERMANY CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY HEART VALVE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 178. GERMANY CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PERFUSION DISPOSABLES, 2018-2030 (USD MILLION)
  • TABLE 179. GERMANY CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 180. GERMANY CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 181. ISRAEL CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 182. ISRAEL CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY CARDIOPULMONARY BYPASS EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 183. ISRAEL CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY HEART VALVE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 184. ISRAEL CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PERFUSION DISPOSABLES, 2018-2030 (USD MILLION)
  • TABLE 185. ISRAEL CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 186. ISRAEL CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 187. ITALY CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 188. ITALY CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY CARDIOPULMONARY BYPASS EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 189. ITALY CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY HEART VALVE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 190. ITALY CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PERFUSION DISPOSABLES, 2018-2030 (USD MILLION)
  • TABLE 191. ITALY CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 192. ITALY CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 193. NETHERLANDS CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 194. NETHERLANDS CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY CARDIOPULMONARY BYPASS EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 195. NETHERLANDS CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY HEART VALVE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 196. NETHERLANDS CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PERFUSION DISPOSABLES, 2018-2030 (USD MILLION)
  • TABLE 197. NETHERLANDS CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 198. NETHERLANDS CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 199. NIGERIA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 200. NIGERIA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY CARDIOPULMONARY BYPASS EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 201. NIGERIA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY HEART VALVE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 202. NIGERIA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PERFUSION DISPOSABLES, 2018-2030 (USD MILLION)
  • TABLE 203. NIGERIA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 204. NIGERIA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 205. NORWAY CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 206. NORWAY CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY CARDIOPULMONARY BYPASS EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 207. NORWAY CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY HEART VALVE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 208. NORWAY CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PERFUSION DISPOSABLES, 2018-2030 (USD MILLION)
  • TABLE 209. NORWAY CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 210. NORWAY CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 211. POLAND CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 212. POLAND CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY CARDIOPULMONARY BYPASS EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 213. POLAND CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY HEART VALVE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 214. POLAND CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PERFUSION DISPOSABLES, 2018-2030 (USD MILLION)
  • TABLE 215. POLAND CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 216. POLAND CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 217. QATAR CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 218. QATAR CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY CARDIOPULMONARY BYPASS EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 219. QATAR CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY HEART VALVE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 220. QATAR CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PERFUSION DISPOSABLES, 2018-2030 (USD MILLION)
  • TABLE 221. QATAR CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 222. QATAR CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 223. RUSSIA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 224. RUSSIA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY CARDIOPULMONARY BYPASS EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 225. RUSSIA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY HEART VALVE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 226. RUSSIA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PERFUSION DISPOSABLES, 2018-2030 (USD MILLION)
  • TABLE 227. RUSSIA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 228. RUSSIA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 229. SAUDI ARABIA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 230. SAUDI ARABIA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY CARDIOPULMONARY BYPASS EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 231. SAUDI ARABIA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY HEART VALVE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 232. SAUDI ARABIA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PERFUSION DISPOSABLES, 2018-2030 (USD MILLION)
  • TABLE 233. SAUDI ARABIA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 234. SAUDI ARABIA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 235. SOUTH AFRICA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 236. SOUTH AFRICA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY CARDIOPULMONARY BYPASS EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 237. SOUTH AFRICA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY HEART VALVE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 238. SOUTH AFRICA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PERFUSION DISPOSABLES, 2018-2030 (USD MILLION)
  • TABLE 239. SOUTH AFRICA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 240. SOUTH AFRICA CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 241. SPAIN CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 242. SPAIN CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY CARDIOPULMONARY BYPASS EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 243. SPAIN CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY HEART VALVE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 244. SPAIN CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PERFUSION DISPOSABLES, 2018-2030 (USD MILLION)
  • TABLE 245. SPAIN CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 246. SPAIN CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 247. SWEDEN CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 248. SWEDEN CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY CARDIOPULMONARY BYPASS EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 249. SWEDEN CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY HEART VALVE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 250. SWEDEN CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PERFUSION DISPOSABLES, 2018-2030 (USD MILLION)
  • TABLE 251. SWEDEN CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 252. SWEDEN CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 253. SWITZERLAND CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 254. SWITZERLAND CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY CARDIOPULMONARY BYPASS EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 255. SWITZERLAND CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY HEART VALVE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 256. SWITZERLAND CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PERFUSION DISPOSABLES, 2018-2030 (USD MILLION)
  • TABLE 257. SWITZERLAND CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 258. SWITZERLAND CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 259. TURKEY CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 260. TURKEY CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY CARDIOPULMONARY BYPASS EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 261. TURKEY CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY HEART VALVE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 262. TURKEY CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PERFUSION DISPOSABLES, 2018-2030 (USD MILLION)
  • TABLE 263. TURKEY CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 264. TURKEY CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 265. UNITED ARAB EMIRATES CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 266. UNITED ARAB EMIRATES CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY CARDIOPULMONARY BYPASS EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 267. UNITED ARAB EMIRATES CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY HEART VALVE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 268. UNITED ARAB EMIRATES CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PERFUSION DISPOSABLES, 2018-2030 (USD MILLION)
  • TABLE 269. UNITED ARAB EMIRATES CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 270. UNITED ARAB EMIRATES CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 271. UNITED KINGDOM CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 272. UNITED KINGDOM CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY CARDIOPULMONARY BYPASS EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 273. UNITED KINGDOM CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY HEART VALVE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 274. UNITED KINGDOM CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PERFUSION DISPOSABLES, 2018-2030 (USD MILLION)
  • TABLE 275. UNITED KINGDOM CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 276. UNITED KINGDOM CARDIOVASCULAR SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 277. CARDIOVASCULAR SURGERY DEVICES MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 278. CARDIOVASCULAR SURGERY DEVICES MARKET, FPNV POSITIONING MATRIX, 2023